InspireMD Inc. (NSPR) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4 MENORAT HAMAOR ST. TEL AVIV, 6744832 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 33,950 | 39,023 | 42,998 | 40,362 | 4,228 | 4,632 | |||
| Cash and cash equivalents | 9,389 | 9,640 | 13,839 | 11,545 | 4,228 | 4,632 | |||
| Short-term investments | 24,561 | 29,383 | 29,159 | 28,817 | |||||
| Receivables | 1,670 | 2,452 | 1,408 | 1,782 | 1,727 | 1,247 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,360 | 2,106 | 1,846 | 1,689 | 1,697 | 1,621 | |||
| Inventory | 2,360 | 2,106 | 1,846 | 1,689 | 1,697 | 1,621 | |||
| Prepaid expense | 531 | 578 | 476 | 56 | 394 | 655 | |||
| Other undisclosed current assets | 6,631 | 8,657 | 13,171 | ||||||
| Total current assets: | 38,511 | 44,159 | 46,728 | 50,520 | 16,703 | 21,326 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,366 | 1,473 | 1,538 | 1,388 | 1,472 | 1,554 | |||
| Property, plant and equipment | 1,186 | 1,060 | 907 | 873 | 887 | 917 | |||
| Other undisclosed noncurrent assets | 965 | 951 | 847 | 857 | 859 | 856 | |||
| Total noncurrent assets: | 3,517 | 3,484 | 3,292 | 3,118 | 3,218 | 3,327 | |||
| TOTAL ASSETS: | 42,028 | 47,643 | 50,020 | 53,638 | 19,921 | 24,653 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,877 | 6,020 | 4,690 | 4,829 | 4,383 | 5,070 | |||
| Accounts payable | 4,877 | 6,020 | 4,690 | 4,829 | 4,383 | 5,070 | |||
| Total current liabilities: | 4,877 | 6,020 | 4,690 | 4,829 | 4,383 | 5,070 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 2,064 | 2,122 | 2,073 | 1,996 | 2,112 | 2,190 | |||
| Liability, pension and other postretirement and postemployment benefits | 1,150 | 1,084 | 1,011 | 1,026 | 1,031 | 995 | |||
| Operating lease, liability | 914 | 1,038 | 1,062 | 970 | 1,081 | 1,195 | |||
| Total noncurrent liabilities: | 2,064 | 2,122 | 2,073 | 1,996 | 2,112 | 2,190 | |||
| Total liabilities: | 6,941 | 8,142 | 6,763 | 6,825 | 6,495 | 7,260 | |||
| Equity | |||||||||
| Equity, attributable to parent | 35,087 | 39,501 | 43,257 | 46,813 | 13,426 | 17,393 | |||
| Common stock | 2 | 2 | 2 | 2 | 1 | 1 | |||
| Additional paid in capital | 263,618 | 261,000 | 259,351 | 257,729 | 219,266 | 218,977 | |||
| Accumulated deficit | (228,533) | (221,501) | (216,096) | (210,918) | (205,841) | (201,585) | |||
| Total equity: | 35,087 | 39,501 | 43,257 | 46,813 | 13,426 | 17,393 | |||
| TOTAL LIABILITIES AND EQUITY: | 42,028 | 47,643 | 50,020 | 53,638 | 19,921 | 24,653 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,511 | 1,761 | 1,556 | 1,649 | 1,239 | 1,026 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (1,219) | (1,256) | (1,118) | (1,158) | (866) | (828) | ||
| Gross profit: | 292 | 505 | 438 | 491 | 373 | 198 | ||
| Operating expenses | (7,706) | (6,313) | (6,077) | (5,806) | (4,754) | (5,134) | ||
| Operating loss: | (7,414) | (5,808) | (5,639) | (5,315) | (4,381) | (4,936) | ||
| Nonoperating income | 382 | 468 | 461 | 238 | 125 | 119 | ||
| Loss from continuing operations before income taxes: | (7,032) | (5,340) | (5,178) | (5,077) | (4,256) | (4,817) | ||
| Other undisclosed loss from continuing operations | (65) | (28) | ||||||
| Net loss available to common stockholders, diluted: | (7,032) | (5,405) | (5,178) | (5,077) | (4,256) | (4,845) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (7,032) | (5,405) | (5,178) | (5,077) | (4,256) | (4,845) | ||
| Comprehensive loss, net of tax, attributable to parent: | (7,032) | (5,405) | (5,178) | (5,077) | (4,256) | (4,845) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.